SCHEMBL7014263

SCHEMBL7014263

CCOC(=O)Cc1c(CC)cn2cccc(OCc3ccccc3)c12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G1B P04054 2/20 0.39
MAPK14 Q16539 1/20 0.39
CFD P00746 1/20 0.39
TBXAS1 P24557 1/20 0.39
L3MBTL1 Q9Y468 4/20 0.38
NR1H4 Q96RI1 1/20 0.38
GAA P10253 1/20 0.38
MAPK1 P28482 2/20 0.38
PRMT5 O14744 2/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
MRGPRX4 Q96LA9 1/20 0.38
ABCB1 P08183 1/20 0.38
RXRA P19793 1/20 0.38
RXRB P28702 1/20 0.38
RXRG P48443 1/20 0.38
BRD4 O60885 1/20 0.38
LMNA P02545 2/20 0.37
KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7014122 0.87 PLA2G1B (0.53) PLA2G1BMAPK14
SCHEMBL8345231 0.82 KDM4E (0.45) PLA2G1BL3MBTL1GAAMAPK1ALDH1A1
SCHEMBL7011352 0.79 FOLH1 (0.47) PLA2G1BMAPK14L3MBTL1MAPK1ALDH1A1
SCHEMBL5661211 0.76 TBXAS1 (0.53) CFDTBXAS1L3MBTL1NR1H4GAA
SCHEMBL7011022 0.75 KDM4E (0.44) L3MBTL1GAAALDH1A1MAPTTDP1
SCHEMBL3952696 0.73 RXRA (0.49) PLA2G1BL3MBTL1MAPK1MAPTTDP1
SCHEMBL7012444 0.72 PLA2G1B (0.46) PLA2G1BALDH1A1KDM4E
SCHEMBL9080973 0.72 KMT2A (0.41) GAAALDH1A1MAPTLMNAKDM4E
SCHEMBL13794527 0.70 MAPT (0.45) L3MBTL1GAAMAPK1ALDH1A1MAPT
SCHEMBL7052623 0.70 PPIA (0.53) MAPK14L3MBTL1NR1H4MAPK1PRMT5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6645976-B1 Nonpancreatic secretory phospholipase (sPLA2) supressors such as 2-(3-Benzyl-8-hydroxy-2-ethylindolizin-1-yl)acetamide, administered to control release of fatty acid and prevent the arachidonic acid cascade; septic shock ELI LILLY AND COMPANY 2003-11-11 US disclosed
EP-0772596-B1 INDOLIZINE sPLA2 INHIBITORS LILLY CO ELI (US) 2003-10-01 EP disclosed
WO-1996003383-A1 INDOLIZINE sPLA2 INHIBITORS ELI LILLY AND COMPANY (US) 1996-02-08 WO disclosed